URGN R&D to Revenue
Urogen Pharma Ltd · R&D to Revenue
URGN R&D to Revenue
Latest reported23.93%period ending
URGN Quarterly R&D/Revenue (0.00% → 23.93%)
Latest values, visible window
High-resolution chart · PNG
URGN r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 23.9262% | |
| 30.607% | |
| 37.8307% | |
| 50.9715% | |
| 78.1086% | |
| 98.109% | |
| 60.631% | |
| 45.0524% | |
| 70.4962% | |
| 82.4983% | |
| 48.0323% | |
| 49.06% | |
| 54.7992% | |
| 72.6966% | |
| 80.0188% | |
| 81.3381% | |
| 76.1262% | |
| 93.6007% | |
| 80.8829% | |
| 105.0392% | |
| 93.0325% | |
| 140.4542% | |
| 155.7243% | |
| 295.0303% | |
| 2,179.0323% | |
| 0% | |
| 0% | |
| 0% | |
| 55,533.3333% | |
| 0% | |
| 0% | |
| 3,383.0389% | |
| 2,272.8022% | |
| 1,584.6154% | |
| 2,067.5841% | |
| 71.9534% | |
| 0% | |
| 14,021.0526% | |
| 13.5311% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |